Mitotic Evolution of Plasmodium falciparum Shows a Stable Core Genome but Recombination in Antigen Families

PLoS Genetics

Volumn 9, Issue 2, 2013, Pages

  Bopp, Selina E R ^a   Manary, Micah J ^a,b   Bright, A Taylor ^a,b   Johnston, Geoffrey L ^c,d   Dharia, Neekesh V ^a   Luna, Fabio L ^e   McCormack, Susan ^e   Plouffe, David ^e   McNamara, Case W ^e   Walker, John R ^e   Fidock, David A ^c   Denchi, Eros Lazzerini ^f   Winzeler, Elizabeth A ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Columbia University ^*  (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^f SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; CYTOCHROME B; MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; CHROMOSOME 1; CLONE; CROSSING OVER; DRUG RESISTANCE; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENETIC RECOMBINATION; GENOMIC INSTABILITY; IMMUNE EVASION; MITOSIS; MULTIGENE FAMILY; MUTATION RATE; NONHUMAN; PARASITE IMMUNITY; PLASMODIUM FALCIPARUM;

ANTIGENIC VARIATION; ANTIGENS; ATOVAQUONE; CYTOCHROMES B; DRUG RESISTANCE, MULTIPLE; EVOLUTION, MOLECULAR; GENOME, PROTOZOAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOST-PARASITE INTERACTIONS; HUMANS; MALARIA, FALCIPARUM; MITOSIS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PLASMODIUM FALCIPARUM;

EID: 84874788696     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1003293     Document Type: Article

References (68)

1. WHO (2011) World Malaria Report 2011. http://www.who.int/malaria/world_malaria_report_2010/en/index.html.
2. O'Brien C, Henrich PP, Passi N, Fidock DA, (2011) Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr Opin Infect Dis 24: 570-577.
3. A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants. N Engl J Med.
4. Genton B, Betuela I, Felger I, Al-Yaman F, Anders RF, et al. (2002) A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea. The Journal of Infectious Diseases 185: 820-827.
5. Freitas-Junior LH, Bottius E, Pirrit LA, Deitsch KW, Scheidig C, et al. (2000) Frequent ectopic recombination of virulence factor genes in telomeric chromosome clusters of P. falciparum. Nature 407: 1018-1022.
6. Kerr PJ, Ranford-Cartwright LC, Walliker D, (1994) Proof of intragenic recombination in Plasmodium falciparum. Mol Biochem Parasitol 66: 241-248.
7. Duffy MF, Byrne TJ, Carret C, Ivens A, Brown GV, (2009) Ectopic recombination of a malaria var gene during mitosis associated with an altered var switch rate. Journal of molecular biology 389: 453-469.
8. Juliano JJ, Taylor SM, Meshnick SR, (2009) Polymerase chain reaction adjustment in antimalarial trials: molecular malarkey? J Infect Dis 200: 5-7.
9. Juliano JJ, Porter K, Mwapasa V, Sem R, Rogers WO, et al. (2010) Exposing malaria in-host diversity and estimating population diversity by capture-recapture using massively parallel pyrosequencing. Proc Natl Acad Sci U S A 107: 20138-20143.
10. Robinson T, Campino SG, Auburn S, Assefa SA, Polley SD, et al. (2011) Drug-resistant genotypes and multi-clonality in Plasmodium falciparum analysed by direct genome sequencing from peripheral blood of malaria patients. PLoS ONE 6: e23204 doi:10.1371/journal.pone.0023204.
11. Paget-McNicol S, Saul A, (2001) Mutation rates in the dihydrofolate reductase gene of Plasmodium falciparum. Parasitology 122: 497-505.
12. Srivastava IK, Morrisey JM, Darrouzet E, Daldal F, Vaidya AB, (1999) Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol Microbiol 33: 704-711.
13. Looareesuwan S, Viravan C, Webster HK, Kyle DE, Hutchinson DB, et al. (1996) Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg 54: 62-66.
14. Dharia NV, Sidhu AB, Cassera MB, Westenberger SJ, Bopp SE, et al. (2009) Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum. Genome Biology 10: R21.
15. Gardner M, Hall N, Fung E, White O, Berriman M, et al. (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419: 498-511.
16. Mu J, Ferdig MT, Feng X, Joy DA, Duan J, et al. (2003) Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol 49: 977-989.
17. Raj DK, Mu J, Jiang H, Kabat J, Singh S, et al. (2009) Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J Biol Chem 284: 7687-7696.
18. Nam TG, McNamara CW, Bopp S, Dharia NV, Meister S, et al. (2011) A Chemical Genomic Analysis of Decoquinate, a Plasmodium falciparum Cytochrome b Inhibitor. ACS chemical biology 6: 1214-1222.
19. Foster PL, (2006) Methods for determining spontaneous mutation rates. Methods Enzymol 409: 195-213.
20. Niccum BA, Poteau R, Hamman GE, Varada JC, Dshalalow JH, et al. (2012) On an unbiased and consistent estimator for mutation rates. J Theor Biol 300: 360-367.
21. Lynch M, Sung W, Morris K, Coffey N, Landry CR, et al. (2008) A genome-wide view of the spectrum of spontaneous mutations in yeast. Proceedings of the National Academy of Sciences of the United States of America 105: 9272-9277.
22. Haag-Liautard C, Dorris M, Maside X, Macaskill S, Halligan DL, et al. (2007) Direct estimation of per nucleotide and genomic deleterious mutation rates in Drosophila. Nature 445: 82-85.
23. Nachman MW, Crowell SL, (2000) Estimate of the mutation rate per nucleotide in humans. Genetics 156: 297-304.
24. Roach JC, Glusman G, Smit AF, Huff CD, Hubley R, et al. (2010) Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 328: 636-639.
25. Pologe LG, Ravetch JV, (1988) Large deletions result from breakage and healing of P. falciparum chromosomes. Cell 55: 869-874.
26. Biggs BA, Kemp DJ, Brown GV, (1989) Subtelomeric chromosome deletions in field isolates of Plasmodium falciparum and their relationship to loss of cytoadherence in vitro. Proc Natl Acad Sci U S A 86: 2428-2432.
27. Patarapotikul J, Langsley G, (1988) Chromosome size polymorphism in Plasmodium falciparum can involve deletions of the subtelomeric pPFrep20 sequence. Nucleic Acids Res 16: 4331-4340.
28. Shirley MW, Biggs BA, Forsyth KP, Brown HJ, Thompson JK, et al. (1990) Chromosome 9 from independent clones and isolates of Plasmodium falciparum undergoes subtelomeric deletions with similar breakpoints in vitro. Molecular and Biochemical Parasitology 40: 137.
29. Dharia NV, Plouffe D, Bopp SE, Gonzalez-Paez GE, Lucas C, et al. (2010) Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites. Genome Res 20: 1534-1544.
30. Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, et al. (2010) Spiroindolones, a potent compound class for the treatment of malaria. Science 329: 1175-1180.
31. Cowman A, Galatis D, Thompson J, (1994) Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA 91: 1143-1147.
32. Sidhu A, Uhlemann A-C, Valderramos S, Valderramos J-C, Krishna S, et al. (2006) Decreasing pfmdr1 copy number in Plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J Infect Dis 194: 528-535.
33. Frank M, Kirkman L, Costantini D, Sanyal S, Lavazec C, et al. (2008) Frequent recombination events generate diversity within the multi-copy variant antigen gene families of Plasmodium falciparum. Int J Parasitol 38: 1099-1109.
34. Figueiredo LM, Freitas-Junior LH, Bottius E, Olivo-Marin JC, Scherf A, (2002) A central role for Plasmodium falciparum subtelomeric regions in spatial positioning and telomere length regulation. EMBO J 21: 815.
35. Scherf A, Mattei D, (1992) Cloning and characterization of chromosome breakpoints of Plasmodium falciparum: breakage and new telomere formation occurs frequently and randomly in subtelomeric genes. Nucleic Acids Res 20: 1491-1496.
36. Rathod PK, McErlean T, Lee PC, (1997) Variations in frequencies of drug resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America 94: 9389-9393.
37. Lavstsen T, Salanti A, Jensen AT, Arnot DE, Theander TG, (2003) Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions. Malar J 2: 27.
38. Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, et al. (1995) Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 82: 77.
39. McVey M, Lee SE, (2008) MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet 24: 529-538.
40. Scherf A, Hernandez-Rivas R, Buffet P, Bottius E, Benatar C, et al. (1998) Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum. EMBO J 17: 5418.
41. Chen Q, Fernandez V, Sundstrom A, Schlichtherle M, Datta S, et al. (1998) Developmental selection of var gene expression in Plasmodium falciparum. Nature 394: 392-395.
42. Roberts DJ, Craig AG, Berendt AR, Pinches R, Nash G, et al. (1992) Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 357: 689.
43. Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, et al. (1995) Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82: 101.
44. Mancio-Silva L, Rojas-Meza AP, Vargas M, Scherf A, Hernandez-Rivas R, (2008) Differential association of Orc1 and Sir2 proteins to telomeric domains in Plasmodium falciparum. Journal of cell science 121: 2046-2053.
45. Freitas-Junior LH, Hernandez-Rivas R, Ralph SA, Montiel-Condado D, Ruvalcaba-Salazar OK, et al. (2005) Telomeric heterochromatin propagation and histone acetylation control mutually exclusive expression of antigenic variation genes in malaria parasites. Cell 121: 25.
46. Pays E, Laurent M, Delinte K, Van Meirvenne N, Steinert M, (1983) Differential size variations between transcriptionally active and inactive telomeres of Trypanosoma brucei. Nucleic acids research 11: 8137-8147.
47. Volkman SK, Sabeti PC, DeCaprio D, Neafsey DE, Schaffner SF, et al. (2007) A genome-wide map of diversity in Plasmodium falciparum. Nat Genet 39: 113-119.
48. World, Health, Organization (2008) Methods and techniques for clinical trials on antimalarial drug efficacy: Genotyping to Identify Parasite Populations. World Health Organization, Geneva.
49. Walliker D, Quakyi IA, Wellems TE, McCutchan TF, Szarfman A, et al. (1987) Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 236: 1661-1666.
50. Rosario V, (1981) Cloning of naturally occurring mixed infections of malaria parasites. Science 212: 1037-1038.
51. Gardner MJ, Hall N, Fung E, White O, Berriman M, et al. (2002) Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419: 498.
52. Trager W, Jenson J, (1978) Cultivation of malarial parasites. Nature 273: 621-622.
53. Beck HP, (2002) Extraction and purification of Plasmodium parasite DNA. Methods Mol Med 72: 159-163.
54. Plouffe D, Brinker A, McNamara C, Henson K, Kato N, et al. (2008) In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc Natl Acad Sci U S A 105: 9059-9064.
55. Oyola SO, Otto TD, Gu Y, Maslen G, Manske M, et al. (2012) Optimizing Illumina next-generation sequencing library preparation for extremely AT-biased genomes. BMC Genomics 13: 1.
56. Li H, Durbin R, (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
57. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
58. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491-498.
59. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20: 1297-1303.
60. Yang Z, Nielsen R, (2000) Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models. Mol Biol Evol 17: 32-43.
61. Nishant KT, Singh ND, Alani E, (2009) Genomic mutation rates: what high-throughput methods can tell us. Bioessays 31: 912-920.
62. Rosche WA, Foster PL, (2000) Determining mutation rates in bacterial populations. Methods 20: 4-17.
63. Hernandez-Rivas R, Scherf A, (1997) Separation and mapping of chromosomes of parasitic protozoa. Mem Inst Oswaldo Cruz 92: 815-819.
64. Hinterberg K, Scherf A, (1994) PFGE: improved conditions for rapid and high-resolution separation of Plasmodium falciparum chromosomes. Parasitol Today 10: 225.
65. Maddison WPaDRM, (2011) Mesquite: a modular system for evolutionary analysis. Version 2.75 ed.
66. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
67. Istvan ES, Dharia NV, Bopp SE, Gluzman I, Winzeler EA, et al. (2011) Validation of isoleucine utilization targets in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America 108: 1627-1632.
68. Nkrumah LJ, Muhle RA, Moura PA, Ghosh P, Hatfull GF, et al. (2006) Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase. Nat Methods 3: 615-621.